Picture of Kezar Life Sciences logo

KZR — Kezar Life Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

Brief: Kezar Board Unanimously Rejects Unsolicited Concentra Proposal And Adopts Limited Duration Stockholder Rights Plan

Oct 17 (Reuters) - Kezar Life Sciences Inc  KZR.O :
    * KEZAR BOARD UNANIMOUSLY REJECTS UNSOLICITED CONCENTRA
PROPOSAL
AND ADOPTS LIMITED DURATION STOCKHOLDER RIGHTS PLAN
    * KEZAR LIFE SCIENCES INC - BOARD UNANIMOUSLY REJECTS
CONCENTRA'S
$1.10 PER SHARE PROPOSAL
    * KEZAR LIFE SCIENCES INC - RIGHTS PLAN TO EXPIRE ON OCTOBER
17,
2025
    * KEZAR LIFE SCIENCES INC - BOARD SAYS CONCENTRA PROPOSAL
SUBSTANTIALLY UNDERVALUES COMPANY
    * KEZAR LIFE SCIENCES INC: SETS TRIGGER AT 10%

Source text for Eikon:  ID:nBw1JHqlDa 
Further company coverage:  KZR.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Kezar Life Sciences

See all news